Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation (SCT)”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Testing effectiveness (Phase 2)Ended earlyNCT01746173
What this trial is testing

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Who this might be right for
T-cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00553202
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 158
Testing effectiveness (Phase 2)Study completedNCT03700450
What this trial is testing

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 37
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Testing effectiveness (Phase 2)Study completedNCT00599495
What this trial is testing

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)Ended earlyNCT02013375
What this trial is testing

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Who this might be right for
Sickle Cell Disease
Damiano Rondelli, MD 2
Testing effectiveness (Phase 2)UnknownNCT02507479
What this trial is testing

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00681044
What this trial is testing

HD Melphalan and SCT in Patients With IGDD or LCDD

Who this might be right for
Multiple Myeloma
Boston Medical Center 5
Not applicableUnknownNCT02172365
What this trial is testing

Allogeneic SCT for CML, TKI Failure After TKI Failure

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 350
Not applicableStudy completedNCT03821727
What this trial is testing

SCT in Ph Positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaSCT
CANDONI ANNA 441
Large-scale testing (Phase 3)Ended earlyNCT04161885
What this trial is testing

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Cancer
AbbVie 465
Early research (Phase 1)Ended earlyNCT00586274
What this trial is testing

Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT

Who this might be right for
FANCONI ANEMIA
Baylor College of Medicine 1
Testing effectiveness (Phase 2)Looking for participantsNCT05917405
What this trial is testing

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

Who this might be right for
Acute Myeloid Leukemia in Remission
Nantes University Hospital 302
Not applicableLooking for participantsNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Large-scale testing (Phase 3)Active Not RecruitingNCT04217278
What this trial is testing

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Who this might be right for
Acute Myeloid LeukaemiaHigh-risk Myelodysplastic Syndrome
University of Birmingham 333
Large-scale testing (Phase 3)Ended earlyNCT00926575
What this trial is testing

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Who this might be right for
Acute Gastrointestinal Graft vs Host Disease
Soligenix 140
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Not applicableNot Yet RecruitingNCT07381205
What this trial is testing

Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)

Who this might be right for
Transplant Associated Microangiopathy TAMTransplant Complication
Manuel Ricardo Espinoza-Gutarra 85
Not applicableStudy completedNCT01746147
What this trial is testing

Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

Who this might be right for
MDS and AML Prior to Allogeneic SCT
GWT-TUD GmbH 134
Next Page